InterAx Biotech raises €3.1M Series A round
15 January 2019· Villigen, Switzerland· biotech, drug_discovery, ai, computational_biology, b2b, pure_software
To accelerate commercialization of the technology platform which enables intelligent drug candidate design and selection.
Investors
LeadFalcon III Ventures
Also participating
Investiere
About InterAx Biotech
Stage
Grant
Headquarters
Villigen, Switzerland
Founded
2016
Team Size
6–20
Sectors
biotechdrug_discoveryaicomputational_biologyb2bpure_software